These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 573129)

  • 1. Treatment of hypertrophic obstructive cardiomyopathy with verapamil.
    Kaltenbach M; Hopf R; Kober G; Bussmann WD; Keller M; Petersen Y
    Br Heart J; 1979 Jul; 42(1):35-42. PubMed ID: 573129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of hypertrophic cardiomyopathy: relation to pathological mechanisms.
    Kaltenbach M; Hopf R
    J Mol Cell Cardiol; 1985 Jul; 17 Suppl 2():59-68. PubMed ID: 4040978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Conservative medical treatment of hypertrophic myocardiopathies].
    Kaltenbach M; Hopf R
    Z Kardiol; 1982 Dec; 71(12):795-805. PubMed ID: 6891871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Echocardiographic and hemodynamic studies on the influence of verapamil in hypertrophic obstructive cardiomyopathy (author's transl)].
    Schmid P; Pavek P; Klein W
    Z Kardiol; 1979 Feb; 68(2):89-92. PubMed ID: 570768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of hypertrophic obstructive cardiomyopathy with verapamil, a calcium antagonist (author's transl)].
    Kaltenbach M; Hopf R; Keller M
    Dtsch Med Wochenschr; 1976 Aug; 101(35):1284-7. PubMed ID: 8298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertrophic obstructive cardiomyopathy. Effects of acute and chronic verapamil treatment on left ventricular systolic and diastolic function.
    Anderson DM; Raff GL; Ports TA; Brundage BH; Parmley WW; Chatterjee K
    Br Heart J; 1984 May; 51(5):523-9. PubMed ID: 6539120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verapamil therapy in infants with hypertrophic cardiomyopathy.
    Moran AM; Colan SD
    Cardiol Young; 1998 Jul; 8(3):310-9. PubMed ID: 9731645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of verapamil on the left ventricular function in hypertrophic obstructive cardiomyopathy].
    Guo HS
    Zhonghua Xin Xue Guan Bing Za Zhi; 1984 Mar; 12(1):13-6. PubMed ID: 6540163
    [No Abstract]   [Full Text] [Related]  

  • 9. [Non-obstructive hypertrophic cardiomyopathy and systolic compression of 3 coronary arteries. Long-term improvement with verapamil].
    Juliard JM; Charlier P; Nitenberg A; Mérillon JP; Masquet C; Gourgon R
    Ann Med Interne (Paris); 1987; 138(7):512-6. PubMed ID: 3439674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 10-year results and survival of patients with hypertrophic cardiomyopathy treated with calcium antagonists.
    Hopf R; Kaltenbach M
    Z Kardiol; 1987; 76 Suppl 3():137-44. PubMed ID: 3433866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of hypertrophic cardiomyopathy with nifedipine and propranolol in combination].
    Hopf R; Thomas J; Klepzig H; Kaltenbach M
    Z Kardiol; 1987 Aug; 76(8):469-78. PubMed ID: 3673167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study of the effects of verapamil and propranolol therapy in 16 cases of obstructive hypertrophic myocardiopathy].
    Cosnay P; Fauchier JP; Lang M; Casset D; Raynaud P; Lavigne G; Itti R
    Arch Mal Coeur Vaiss; 1987 Mar; 80(3):346-55. PubMed ID: 3113357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Left ventricular relaxation in hypertrophic cardiomyopathy and possibilities of controlling it with verapamil].
    Gregor P; Widimský P; Cervenka V; Vísek V; Sládková T; Dvorák J
    Cas Lek Cesk; 1987 Mar; 126(11):330-4. PubMed ID: 3829106
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug treatment of hypertrophic cardiomyopathy].
    Hirzel HO
    Herz; 1985 Apr; 10(2):84-90. PubMed ID: 4039293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term treatment of hypertrophic non obstructive cardiomyopathy (HNCM) with verapamil (author's transl)].
    Kuhn H; Thelen U; Leuner C; Köhler E; Bluschke V
    Z Kardiol; 1980 Oct; 69(10):669-75. PubMed ID: 7192910
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of verapamil on the indicators of left-ventricular diastole in hypertrophic cardiomyopathy].
    Dabrowski M; Górecka B; Witkowski A; Jodkowski J; Woroszylska M; Ruzyłło W
    Kardiol Pol; 1986; 29(5-6):345-55. PubMed ID: 3784250
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of verapamil in the treatment of hypertrophic cardiomyopathy.
    Gregor P; Widimský P; Cervenka V; Vísek V; Sládková T; Dvorák J
    Cor Vasa; 1986; 28(6):404-12. PubMed ID: 3829686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regression of outflow tract obstruction subsequent to treatment with verapamil in hypertrophic obstructive cardiomyopathy.
    Frandsen F; Mickley H
    Int J Cardiol; 1990 Sep; 28(3):375-6. PubMed ID: 2210905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic verapamil therapy in pediatric and young adult patients with hypertrophic cardiomyopathy.
    Spicer RL; Rocchini AP; Crowley DC; Rosenthal A
    Am J Cardiol; 1984 Jun; 53(11):1614-9. PubMed ID: 6539561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Systolic and diastolic intervals in patients with hypertrophic obstructive cardiomyopathy before and after withdrawal of verapamil].
    Jandík J; Kvasnicka J; Vokrouhlický L
    Bratisl Lek Listy; 1990 Sep; 91(9):701-4. PubMed ID: 2224552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.